Home › Funds › Invesco › Invesco Nasdaq Future Gen 200 ETF
Fund family: Invesco · Filed by Invesco Exchange-Traded Fund Trust II (CIK 1378872) · SEC series S000077288
Ticker: QQQS (C000237581)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 1,694 with, 9 against, 0 abstentions (not counted as with management); 1 items carried no recommendation. Shareholder proposals: 0 FOR, 6 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as Invesco’s manager page (413,145 ballot items across 270 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Invesco | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 92.5% | 1,621 | 94.5% | 357,245 |
| Backed environmental and social shareholder proposals at US companies | n/a | 1 | 3.1% | 5,987 |
Each ballot item this fund voted is set against the votes of the other Invesco funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most Invesco funds on 1 item (0.1% of the 946 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most Invesco funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| iHeartMedia, Inc. | 2026-06-04 | The approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. | Against | FOR — 7 of 11 Invesco funds | Against | Passed (calculated), 84.4% support |
Download all 1 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 90.9% of this fund’s 1,703 such votes could be given a sector; the other 155 (9.1%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Health Care | 650 | 4 | 0.6% |
| Technology | 465 | 3 | 0.6% |
| Consumer Discretionary | 194 | 0 | 0.0% |
| Industrials | 152 | 2 | 1.3% |
| Telecommunications | 40 | 0 | 0.0% |
| Basic Materials | 11 | 0 | 0.0% |
| Miscellaneous | 11 | 0 | 0.0% |
| Energy | 10 | 0 | 0.0% |
| Utilities | 8 | 0 | 0.0% |
| Consumer Staples | 7 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 1,070 | 3 |
| Audit-related | 194 | 0 |
| Say-on-Pay | 193 | 0 |
| Compensation | 138 | 0 |
| Corporate Governance | 69 | 5 |
| Capital Structure | 25 | 0 |
| Extraordinary Transactions | 17 | 0 |
| Shareholder Rights and Defenses | 10 | 0 |
| Environment or Climate | 1 | 1 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| ViaSat, Inc. | September 4, 2025 | $273,875 | 6 | 0 |
| MaxLinear, Inc. | May 20, 2026 | $210,842 | 6 | 0 |
| Bandwidth Inc. | May 28, 2026 | $195,761 | 5 | 0 |
| Rapid7, Inc. | June 9, 2026 | $167,451 | 13 | 0 |
| CryoPort, Inc. | June 5, 2026 | $166,736 | 9 | 0 |
| Maravai Lifesciences Holdings, Inc. | May 26, 2026 | $147,378 | 5 | 0 |
| Axogen, Inc. | June 23, 2026 | $126,931 | 10 | 0 |
| AtriCure, Inc. | May 18, 2026 | $125,443 | 13 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 6, 2026 | Entegris, Inc. | Stockholder Proposal: Providing stockholders the right to call special meetings of stockholders. Shareholder proposal | Against | For |
| June 9, 2026 | Pacira Biosciences, Inc. | Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Company Nominees: DOMA Nominees Opposed by the Company: Oliver Benton Curtis III Shareholder proposal | Withhold | For |
| June 9, 2026 | Pacira Biosciences, Inc. | Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Company Nominees: DOMA Nominees Opposed by the Company: Eric de Armas Shareholder proposal | Withhold | For |
| May 13, 2026 | Skyworks Solutions, Inc. | To approve a stockholder proposal regarding greenhouse gas emission reduction efforts report. Shareholder proposal | Against | For |
| May 11, 2026 | MKS Inc. | A shareholder proposal to reduce the threshold percentage of shareholders required to call a special meeting of shareholders from 40% to 10%, if properly presented at the meeting. Shareholder proposal | Against | For |
| May 13, 2026 | ICU Medical, Inc. | To approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right. Shareholder proposal | Against | For |
| June 3, 2026 | Power Integrations, Inc. | To consider, if properly presented at the Annual Meeting, a stockholder proposal related to the separation of the office of Chairman of the Board and the office of Chief Executive Officer. Shareholder proposal | Against | For |
| August 13, 2025 | Qorvo, Inc. | To consider a stockholder proposal relating to special meetings of Qorvo, Inc.'s stockholders, if properly presented. Shareholder proposal | Against | For |
Meetings with a proxy contest or competing nominees (1 in 2025-2026), and how the fund voted the items on its ballot.
1,717 ballot items at 209 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Invesco Nasdaq Future Gen 200 ETF (QQQS) voted at 209 shareholder meetings of 197 companies, on 1,717 ballot items in all. Where management made a recommendation, the fund followed it on 99.5% of the items and voted against it 9 times. Its most frequent area of disagreement was corporate governance (5 of its votes against management). It voted on 9 shareholder proposals. It voted FOR the board's own proposals less often than Invesco's funds as a whole (92.5% against 94.5%). It voted differently from most Invesco funds on 1 item. 1 of its meetings was contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Invesco’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.